Global Gastric Cancer Market
Healthcare Services

Unlocking Opportunities in the Gastric Cancer Market: Key Trends, Market Growth, and Forecast Insights

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theGastric Cancer Market?

The escalating rates of obesity are anticipated to fuel the expansion of the gastric cancer market. Obesity is a health issue characterized by an extreme accumulation of body fat, typically measured by a body mass index (BMI) of 30 or more, leading to numerous health complications. The increase in obesity rates is due to several factors such as unhealthy eating habits, lack of physical movement, a sedentary lifestyle, environmental influences, and inherited predispositions. Excessive body fat, especially visceral fat located around the abdomen, can lead to a higher risk of gastric cancer due to obesity-induced chronic inflammation and metabolic disorders, both are connected to cancer progression, thus increasing the need for gastric cancer treatments. For example, according to the World Health Organization in March 2024, a Switzerland-based international organization, around 1 in 8 people worldwide were suffering from obesity in 2022, with 2.5 billion adults aged 18 and above being categorized as overweight, including 890 million individuals struggling with obesity. Among adults, 43% were overweight, and 16% were obese. Moreover, 37 million children below the age of 5 were overweight, and over 390 million children and adolescents between the ages of 5–19 were overweight, including 160 million who were obese. Thus, the escalating rates of obesity are steering the growth of the gastric cancer market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

#How Will the CAGR of the Gastric Cancer Market Influence Its Overall Growth by 2034?

The market size for gastric cancer has witnessed a brisk expansion in recent years. It is predicted to escalate from $3.17 billion in 2024 to $3.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.4%. Factors contributing to the growth during the historical period include the surge in the elderly population, amplified consciousness about healthcare, heightened genetic mutations, increase in unhealthy lifestyle habits, and escalating knowledge regarding cancer.

The market size for gastric cancer is anticipated to witness swift expansion in the upcoming years. By 2029, it is predicted to reach $6.43 billion, with a compound annual growth rate (CAGR) of 15.2%. This increase during the predicted period is due to factors such as an increase in obesity, expansion of government initiatives, increased investments in healthcare, a surge in demand for oral medications, and growing number of facilities for cancer treatment. Key trends anticipated in the forecast period involve combination chemotherapy, product expansion, robotic-assisted surgeries, targeted treatments, strategic collaborations, and advanced diagnostic tools.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20797

Which Cutting-Edge Market Trends Are Expected to Drive theGastric Cancer Market’s Growth?

Major players in the gastric cancer market are concentrating on the innovation of technologically superior solutions like companion diagnostic assays. These assays aid in personalising treatment by identifying patients likely to positively respond to particular therapeutic remedies based on the presence of specific biomarkers. A case in point is from October 2024 when F. Hoffmann-La Roche Ltd, a pharmaceutical firm located in Switzerland, received the green light from the U.S. Food and Drug Administration (FDA) for the VENTANA CLDN18 (43-14A) RxDx Assay. This was the first-ever immunohistochemistry (IHC) companion diagnostic dedicated to assessing CLDN18 protein expression in both gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay determines the patients who are suitable for targeted engagement with VYLOY (zolbetuximab) by gauging CLDN18 protein variances, particularly CLDN18.2. By using the OptiView DAB IHC Detection Kit with the BenchMark ULTRA tool, this test boosts personalized healthcare and widens the scope of treatment possibilities for gastric and GEJ adenocarcinoma.

What Are the Leading Market Players Impacting theGastric Cancer Market’s Growth Trend?

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Samsung Biologics Co. Ltd., Celltrion Healthcare Co. Ltd., Biocon Limited, Hanmi Pharmaceuticals, Mylan N.V., Taiho Oncology Inc., Hikma Pharmaceuticals PLC, Taiho Pharmaceuticals Co. Ltd., AROG Pharmaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

How Are the Key Segments of the Gastric Cancer Market Driving Opportunities and Innovations?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20797&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theGastric Cancer Market?# Market Expansion?

North America was the largest region in the gastric cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Gastric Cancer Market 2025, By The Business Research Company:

Gastric Cancer Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: